Hemab

A lean first quarter for venture-backed developers
EP Vantage
Wed, 04/5/23 - 10:02 am
funding
venture capital
ArriVent Biopharma
Flare Therapeutics GSK
Hemab
Hemab raises $55M to target multiple rare bleeding indications
Fierce Biotech
Thu, 07/22/21 - 10:55 am
Hemab
funding
monoclonal antibodies
bispecific antibodies
Novo invests in Hemab, a company going against the hemophilia gene therapy grain with a plan for bispecifics
Endpoints
Mon, 12/14/20 - 10:53 am
Novo Nordisk
Novo Holdings
Hemab
hemophilia